Dianthus Therapeutics Inc reports results for the quarter ended in June - Earnings Summary

Dianthus Therapeutics

08/08/2024 22:27

* Dianthus Therapeutics Inc  DNTH.OQ  reported a quarterly
adjusted loss of 51 cents​​ per share for the quarter ended in
June, higher than the same quarter last year, when the company
reported EPS of -80 cents.  The mean expectation of
nine analysts for the quarter was for a loss of 55 cents per
share. Wall Street expected results to range from -85 cents
to -28 cents per share.
    * Revenue was $1.86 million​; analysts expected $322.75
thousand. 
    * Dianthus Therapeutics Inc's reported EPS for the quarter
was a
loss of 51 cents​.
    * The company reported a quarterly loss of $17.61 million.
    * Dianthus Therapeutics Inc shares had fallen by 0.3% this
quarter and gained 148.1% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 20.2%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 10 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is  "buy."

Wall Street's median 12-month price target for Dianthus
Therapeutics Inc is $45.00 
This summary was machine generated from LSEG data August 8 at
09:27 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2024      -0.55          -0.51          Beat
 Mar. 31 2024      -0.44          -0.54          Missed
 Dec. 31 2023      -1.01          -0.71          Beat
 Sep. 30 2023      -0.56          -3.78          Missed